By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mayne Pharma USA Inc. (Formerly Known as Faulding Pharmaceutical Company) 

Americas Head Office
650 From Road, Mack-Cali Centre II - Second Floor
Paramus  New Jersey    U.S.A.
Phone: 201-225-5500 Fax: 201-225-5515



Company News
Mayne Pharma USA Inc. Announces The Launch Of Epirubicin Hydrochloride For Injection 11/6/2006 11:17:43 PM
Bioenvision (BIOV) And Mayne Pharma USA Inc. Announce Marketing And Distribution Agreement For Evoltra(R) 5/16/2006 1:44:44 PM
Mayne Pharma USA Inc. Announces FDA Approval Of Mitoxantrone 4/12/2006 10:27:04 AM
Mayne Pharma USA Inc. Adds Carboplatin 600MG/60ML Injection To Its Product Line10/19/2005 5:12:48 PM
Mayne Pharma USA Inc. Adds Carboplatin Injection To Its Product Line 10/19/2005 5:11:50 PM
aaiPharma Inc. (AAII) Completes Asset Sale And Closes On New $140 Million Credit Facility; Company Achieves Financing Goals10/19/2005 5:11:03 PM
aaiPharma Inc. (AAII) To Sell M.V.I.(R) Product Business To Mayne Pharma USA Inc.; aaiPharma Will Receive $100 Million In Cash10/19/2005 5:10:13 PM
IVAX Corporation (IVX) To Distribute Mayne Pharma Injectable Oncology Products In Central And Eastern Europe10/19/2005 5:09:24 PM
Faulding Pharmaceutical Co. And Faulding Puerto Rico, Inc. Announces Change Of Its Corporate Names To Mayne Pharma (USA) Inc. And Mayne Pharma (Pr) Inc.10/19/2005 5:09:18 PM
Mayne Pharma USA Inc. Receives FDA Approval For Multi Dose Carboplatin10/19/2005 5:09:00 PM